logo
Plus   Neg
Share
Email

Allergan: FDA Approves BOTOX For Pediatric Patients With Upper Limb Spasticity

Allergan plc (AGN) announced U.S. FDA approval of the company's sBLA for BOTOX for the treatment of pediatric patients with upper limb spasticity. BOTOX is the First Neurotoxin treatment approved to treat patients of, 2 to 17 years of age, for the therapeutic Indication. The approval was based on data from two Phase 3 studies evaluating BOTOX in over 200 pediatric patients.

The company's additional sBLA for the use of BOTOX to treat pediatric patients with lower limb spasticity, is currently under FDA review, and a decision is expected in the fourth quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla has earned the highest safety award from the Insurance Institute for Highway Safety or IIHS for the first time. The luxury electric car maker's Model 3 midsize luxury sedan won the IIHS's Top Safety Pick+ award. The Model 3 is the second plug-in vehicle with no gas engine to earn the Top Safety Pick+ award after Audi's e-tron SUV. Facebook expanded the Portal family of home video-calling devices almost one year after their launch by introducing three new models - Portal, Portal Mini and Portal TV. While the Facebook Portal and the Facebook Portal Mini are the successors to last year's Portal and Portal+ smart cameras-cum-displays, the Facebook Portal TV can convert a smart TV into a giant video-calling screen. Kichler Lighting LLC recalled 1,039 units of Elan Shayla mini pendant lights for concerns of fire hazard. These include 289 units sold in Canada. The light sockets of the recalled pendant lights can overheat, melt, or catch fire, posing a fire hazard, a statement published by the U.S. Consumer Product Safety Commission said.
Follow RTT